Plerixafor and Filgrastim XM02 (Tevagastrim) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantation.

Andreola, Giovanna; Babic, Aleksandra; Rabascio, Cristina; Negri, Mara; Martinelli, Giovanni; Laszlo, Daniele

Andreola, Giovanna; Babic, Aleksandra; Rabascio, Cristina; Negri, Mara; Martinelli, Giovanni; Laszlo, Daniele.

Affiliation

Andreola G; Stem Cell Collection Unit, European Institute of Oncology, Milan, Italy.

Eur J Haematol ; 88(2): 154-8, 2012 Feb.

Article in En | MEDLINE | ID: mdl-21992403

Subject(s)

Bone Marrow Transplantation; Granulocyte Colony-Stimulating Factor/administration & dosage; Hematopoietic Stem Cell Mobilization/methods; Heterocyclic Compounds/administration & dosage; Lymphoma/surgery; Multiple Myeloma/surgery; Adult; Aged; Antigens, CD34/metabolism; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Benzylamines; Combined Modality Therapy; Cyclams; Female; Filgrastim; Granulocyte Colony-Stimulating Factor/adverse effects; Heterocyclic Compounds/adverse effects; Humans; Male; Middle Aged; Recombinant Proteins/administration & dosage; Recombinant Proteins/adverse effects; Transplantation, Autologous; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Granulocyte Colony-Stimulating Factor / Bone Marrow Transplantation / Hematopoietic Stem Cell Mobilization / Heterocyclic Compounds / Lymphoma / Multiple Myeloma Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2012 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google